Ross Davidson
Internal Medicine · Albuquerque, NMNPI 1972998912
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (46.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 92.5% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $6,000 and has fallen 99.0% since, to $57 in 2025. Among internal medicine clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 31 payments — averaging $209.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$6K
- AstraZeneca$273
- United Therapeutics Corporation$127
- Noah Medical Corporation$43
- Medline Industries LP$23
- Ambu Inc.$22
What the payments were for
- Travel & lodging$2,52839%
- Food & beverage$97915%
- Education$3,00046%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 23 | $6,020 |
| AstraZeneca | 4 | $273 |
| United Therapeutics Corporation | 1 | $127 |
| Noah Medical Corporation | 1 | $43 |
| Medline Industries LP | 1 | $23 |
| Ambu Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$5,582
- BREZTRI$125
- TEZSPIRE$125
How this compares
$6,507 in reported general payments places this provider in the 95th percentile of 578 internal medicine providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 15 | $194,484 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 139 | $114,276 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 49 | $46,783 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 28 | $19,689 |
| Spiriva RespimatTiotropium Bromide | 22 | $15,833 |
| Breo ElliptaFluticasone/Vilanterol | 19 | $9,445 |
| SymbicortBudesonide/Formoterol Fumarate | 26 | $8,526 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 16 | $6,307 |
| Arnuity ElliptaFluticasone Furoate | 15 | $5,011 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 95 | $3,909 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 27 | $3,240 |
| Ethambutol Hcl | 12 | $859 |
| Rifampin | 12 | $745 |
| Ipratropium Bromide | 26 | $572 |
| Roflumilast | 19 | $542 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere | $273 | $61,61691 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 578 internal medicine providers in New Mexico.
Other internal medicine in Albuquerque
- Edward LewieckiAlbuquerque$491K
- James AdairAlbuquerque$108K
- Gulshan ParasherAlbuquerque$66K
- Mark WalkerAlbuquerque$24K
- Joao TeixeiraAlbuquerque$18K
- Karla AlmarazAlbuquerque$18K
- David SosaAlbuquerque$11K
- Revati ReddyAlbuquerque$7K
- Edmee RodriguezAlbuquerque$6K
- Anthony ChuangAlbuquerque$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.